3 unknown, 2 completed. 3 Early Phase 1, 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Unknown 2, Completed 1 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Clinical Testing of Beverly Hills: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Purified Exosome Product (PEP) Injected Into the Hypodermis PEP (Purified Exosome Product) - Safety | Phase 1 | Completed | Clinical Testing of Beverly Hills | 8 | 2025-04-14 | 2025-12-26 |
| Xeomin Treatment of Glabellar Lines Using OLD Versus COLD IncobotulinumtoxinA - Glabellar Frown Lines | Early Phase 1 | Unknown | Clinical Testing of Beverly Hills | 40 | 2022-05-01 | 2022-03-31 |
| Jeuveau Treatment of Glabellar Lines Using OLD Versus COLD prabotulinumtoxinA - Glabellar Frown Lines | Early Phase 1 | Completed | Clinical Testing of Beverly Hills | 30 | 2021-12-16 | 2024-02-06 |
| Duration of Botox Using OLD Versus COLD for Treatment of Glabellar Lines OnabotulinumtoxinA - Glabellar Frown Lines | Early Phase 1 | Unknown | Clinical Testing of Beverly Hills | 40 | 2021-10-20 | 2021-10-27 |
| Dysport Dose-Ranging Treatment of Platysmal Bands AbobotulinumtoxinA - Platysma Bands | Phase 1 / Phase 2 | Unknown | Clinical Testing of Beverly Hills | 30 | 2021-05-30 | 2022-10-12 |
Botulinum Toxins, Type A (1) · abobotulinumtoxinA (1) · incobotulinumtoxinA (1) · prabotulinumtoxin A (1)
United States (5)
John Joseph, MD (4) · John H Joseph, MD (1)